<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02384759</url>
  </required_header>
  <id_info>
    <org_study_id>PRODIGE25</org_study_id>
    <nct_id>NCT02384759</nct_id>
  </id_info>
  <brief_title>Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers</brief_title>
  <acronym>FOLFA</acronym>
  <official_title>Phase II Randomized Trial Evaluting Aflibercept Associated With LV5FU2 Regimen as First Line Treatment of Non-resectalbe Metastatic Colorectal Cancers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federation Francophone de Cancerologie Digestive</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federation Francophone de Cancerologie Digestive</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is what the FFCD 11-01 - PRODIGE 25 trial proposes to study, as a preliminary for
      strategic studies evaluating the usefulness of including targeted therapeutics from the first
      line with aflibercept +/- LV5FU2.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aflibercept-5-FU combination has never been evaluated as yet. Aflibercept, at a dose of 4
      mg/kg, has already been used in combination with 5-FU at the doses used in the simplified
      LV5FU2 regimen (folinic acid 400 mg/m2 IV in 90 min, then 5-FU 400 mg/m2 IV bolus on D1,
      followed by continuous perfusion of 5-FU 2,400 mg/m2 in 46h) (23) as part of the
      above-mentioned VELOUR trial, evaluating its combination with FOLFIRI (= simplified LV5FU2 +
      irinotecan). This trial was preceded by a phase I trial validating the doses used (24). It is
      therefore not necessary to perform a phase I trial if you use the same doses of 5-FU without
      irinotecan, within the context of a strategy for reducing toxicity in patients to be treated
      over a long period, and not search for the maximum tolerated dose of the combination.

      The aflibercept-LV5FU2 combination can be useful for patients who will never be resectable or
      operable, and for whom 5-FU monotherapy can be suggested to delay the toxicities of combined
      chemotherapies. Within this context, it is possible for aflibercept to provide a survival
      benefit. The previous VELOUR trial (18) did not indicate that toxicity would have a major
      effect on quality of life and increase the hope of prolonged progression-free survival in the
      arm with aflibercept.

      This is what the FFCD 11-01 - PRODIGE 25 trial proposes to study, as a preliminary for
      strategic studies evaluating the usefulness of including targeted therapeutics from the first
      line.

      This trial will evaluate the efficacy of the combination and its tolerance by studying
      toxicities and quality of life. Quality of life will be studied via the EORTC questionnaire
      QLQ-C30.

      The thymidylate synthase polymorphism type 2R2R-2R3R versus 3R3R seems to predict greater
      efficacy of 5-FU monotherapy. Stratification in this criterion will confirm or negate the
      prognostic or predictive nature of 5-FU efficacy linked to these polymorphisms.

      The draft version of this trial has been studied and evaluated by the scientific council of
      the Fédération Francophone de Cancérologie Digestive (FFCD) then the Digestive Group of the
      Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) within the framework of
      their Partnership for Research in Digestive Oncology (PRODIGE cooperation).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiological progression-free survival according to the investigator</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Efficacy of aflibercept combined with 5-FU monotherapy, on progression-free (radiological only) survival within 6 months after the randomization, according to the investigator.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aflibercept tolerance withe LV5FU2</measure>
    <time_frame>up to 6 months, 2 years and 3 years</time_frame>
    <description>Aflibercept tolerance in combination with 5-FU and folinic acid, evaluated by toxicities graded according to NCI-CTC V4.0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>up to 6 months, 2 years and 3 years</time_frame>
    <description>Quality of life using the EORTC QLQ-C30 questionnaire and time to final deterioration in quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>up to 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological progression-free survival accordint to central reading</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Proportion of patients alive and without progression (radiological) within 6 months (RECIST 1.1) according to central reading</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical and radiological progression-free survival according to the investigator</measure>
    <time_frame>up to 6 months and 1 year</time_frame>
    <description>Proportion of patients alive and without progression (RECIST 1.1) within 6 months and 1 year according to the investigator (Progression defined as clinical and/or radiological progression).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best response</measure>
    <time_frame>up to 1 year</time_frame>
    <description>Best response to study treatment (RECIST 1.1 criteria)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Curative resectability</measure>
    <time_frame>up to 1 year</time_frame>
    <description>Curative resectability</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">118</enrollment>
  <condition>Colorectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aflibercept + LV5FU2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>LV5FU2</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>aflibercept</intervention_name>
    <arm_group_label>A</arm_group_label>
    <other_name>zaltrap</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LV5FU2</intervention_name>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 65 years

          -  General condition WHO ≤ 2

          -  Metastatic rectal or colonic adenocarcinoma, histologically proved on the primary
             tumour or a metastasis

          -  Metastases non-resectable and/or patient inoperable

          -  patients where a single agent chemotherapy combined with an anti-angiogenic agent is
             an appropriate approach

          -  At least one measurable target according to RECIST v1.1 criteria, no previously
             irradiated

          -  No previous treatment of the metastatic disease. Previous chemotherapy in an adjuvant
             situation completed 6 months or more before diagnosis of the metastasis is authorized.

          -  Adequate biological examination: Hb &gt; or = 9 g/dl, polynuclear neutrophils &gt; or =
             1,500/mm3, platelets &gt; or =100,000/mm3, total bilirubin &lt; or = 1.5 x UNL, creatinine
             clearance, calculated according to Cockroft-Gault formula, &gt; 50 ml/min creatininemia &lt;
             1.5 x UNL, ALP &lt; 5 x UNL, transaminases &lt; 5 x ULN, GGT&lt; 5 x UNL

          -  Proteinuria (strip) &lt; 2+; if &gt; or = 2+, test proteinuria over 24 hours which must be ≤
             1 g.

          -  Central genotyping of thymidylate synthase (TS) in blood DNA

          -  Patients treated with anticoagulants (coumadin, warfarin) can be included if the INR
             can be closely monitored. A change in anticoagulant treatment for low molecular weight
             heparin is preferable in order to respect indications

          -  Signed written informed consent obtained prior to inclusion

        Exclusion Criteria:

          -  Patients with a primary tumour in place and presenting clinical symptoms (occlusion,
             haemorrhage)

          -  History of brain metastases, uncontrolled spinal cord compression, or carcinomatous
             meningitis or new evidence of brain or leptomeningeal disease.

          -  Uncontrolled hypercalcemia

          -  Uncontrolled hypertension (SBP &gt; 150 mmHg and DBP &gt; 100 mmHg) or history of
             hypertensive attacks or hypertensive encephalopathy

          -  Any progressive pathology not balanced over the past 6 months: hepatic insufficiency,
             renal insufficiency, respiratory insufficiency,

          -  Any of the following within 6 months prior to inclusion: myocardial infarction,
             severe/unstable angina pectoris, coronary/peripheral artery bypass graft, NYHA class
             III or IV congestive heart failure, stroke or transient ischemic attack.

          -  Any of the following within 3 months prior to inclusion: Grade 3-4 gastrointestinal
             bleeding/hemorrhage, treatment resistant peptic ulcer disease, erosive oesophagitis or
             gastritis, infectious or inflammatory bowel disease, diverticulitis, pulmonary
             embolism or other uncontrolled thromboembolic event, wound or fractured bone

          -  Major surgery during the 28 days preceding the start of treatment

          -  Known acquired immunodeficiency syndrome (AIDS-related illnesses) or known HIV disease
             requiring antiretroviral treatment.

          -  Treatment with concomitant anticonvulsivant agents that are CYP3A4 inducers
             (phenytoin, phenobarbital, carbamazepine), unless discontinued &gt;7 days.

          -  Anti-tumoral treatments other than the trial treatments (chemotherapy, targeted
             therapy, immunotherapy)

          -  Macronodular peritoneal carcinosis (risk of perforation)

          -  Known DPD deficit

          -  Prior history of malignant haemopathy or cancer except those treated more than 5 years
             ago and considered to be cured, in situ cervical carcinomas and treated skin cancers
             (excluding melanoma)

          -  Patients on new oral anticoagulant therapy (rivaroxaban XARELTOR, apixaban ELIQUIS,
             dagigatran PRADAXA except if relay by vitamine K antagonist therapy)

          -  Any contraindication to the treatments used in the trial

          -  Impossibility of undergoing medical monitoring during the trial for geographic, social
             or psychological reasons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Louis LEGOUX, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ORLEANS - Centre Hospitalier La Source</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lila GABA</last_name>
    <phone>+33 3 80 39 34 83</phone>
    <email>lila.gaba@u-bourgogne.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Aix En Provence</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie NAHON BRISSONNEAU</last_name>
      <email>snahon@ch-aix.fr</email>
    </contact>
    <investigator>
      <last_name>Sophie NAHON BRISSONNEAU</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICO</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique GUERIN-MEYER</last_name>
      <email>veronique.guerin-meyer@ico.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Véronique GUERIN-MEYER</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Judith RAMBOURG</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jaafar BENNOUNA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin LINOT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier CAPITAIN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Auxerre</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Laure VILLING</last_name>
      <email>alvilling@ch-auxerre.fr</email>
    </contact>
    <investigator>
      <last_name>Anne-Laure VILLING</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de la Côte Basque</name>
      <address>
        <city>Bayonne</city>
        <zip>64109</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franck AUDEMAR, MD</last_name>
      <phone>+33 5 59 44 37 29</phone>
      <email>faudemar@ch-cotebasque.fr</email>
    </contact>
    <investigator>
      <last_name>Franck AUDEMAR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne CADIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne GUILNGAR, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benoît OUI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tam KHUONG, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre D'Oncologie Et de Radiothérapie</name>
      <address>
        <city>Bayonne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane REMY</last_name>
      <email>stephane.remy@oncologie-pays-basque.org</email>
    </contact>
    <investigator>
      <last_name>Stéphane REMY</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maciej ROTARSKI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Bezier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed RAMDANI</last_name>
      <email>mohamed.ramdani@ch-beziers.fr</email>
    </contact>
    <investigator>
      <last_name>Mohamed RAMDANI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yann LE BRICQUIR</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana PIGUI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU APHP Hôpital Avicenne</name>
      <address>
        <city>Bobigny</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas APARICIO</last_name>
      <email>thomas.aparicio@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Thomas APARICIO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU- Hôpital Saint André</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis SMITH</last_name>
      <email>denis.smith@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Denis SMITH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alain RAVAUD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marine GROSS-GOUPIL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie TRUFFLANDIER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurence DIGUE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amandine QUIVY</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique Bordeaux Nord</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cédric LECAILLE</last_name>
      <email>lecail@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Cédric LECAILLE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xavier MONCOUCY</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul-Régis MANNANT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre ROUSSY</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laure DUPONT-KAZMA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iris DEVAURE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH - Hôpital Duchenne</name>
      <address>
        <city>Boulogne Sur Mer</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Bourgeois</last_name>
      <email>vincebourgeois@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Vincent Bourgeois</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nacer Eddine ACHOUR</last_name>
      <email>neddineachour@oncologie-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Nacer Eddine ACHOUR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Brive La Gaillarde</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laure VAYRE</last_name>
      <email>laure.vayre@ch-brive.fr</email>
    </contact>
    <investigator>
      <last_name>Laure VAYRE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delia MOLNAR</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Côte de Nacre</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karine BOUHIER LEPORRIER</last_name>
      <email>bouhierleporrier-k@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Karine BOUHIER LEPORRIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Laure BIGNON</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chic Castres -Mazamet</name>
      <address>
        <city>Castres</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hazem HASWANI</last_name>
      <email>hazem.haswani@chic-cm.fr</email>
    </contact>
    <investigator>
      <last_name>Hazem HASWANI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hugo SAADOUN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch</name>
      <address>
        <city>Chambery</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier BERTHELET</last_name>
      <email>olivier.berthelet@ch-metropole-savoie.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier BERTHELET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique médico Chirurgicale</name>
      <address>
        <city>Chaumont</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles DUPONT</last_name>
      <email>gilles.dupont-oncorad.chaumont@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>Gilles DUPONT</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elie KHOURI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Public du Cotentin</name>
      <address>
        <city>Cherbourg En Cotentin</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laure KALUZINSKI</last_name>
      <email>l.kaluzinski@ch-cherbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Laure KALUZINSKI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amr EL WESHI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Nicolas PINHO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Estaing</name>
      <address>
        <city>Clermont Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline PETORIN</last_name>
      <email>cpetorin@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Caroline PETORIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Denis PEZET</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne DUBOIS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Agnès VIMAL-BAGUET</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Alpes Leman</name>
      <address>
        <city>Contamine Sur Arve</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol ALLIOT</last_name>
      <email>calliot@ch-alpes-leman.fr</email>
    </contact>
    <investigator>
      <last_name>Carol ALLIOT</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Bernard BOUCLIER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Floriane HUET PENZ</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Riad SALAME</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Le Bocage</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Louis JOUVE</last_name>
      <email>jean-louis.jouve@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Louis JOUVE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alice GAGNAIRE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurent BEDENNE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Côme LEPAGE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marianne LATOURNERIE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvain MANFREDI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoine DROUILLARD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Elbeuf</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Marie QUEUNIET</last_name>
      <email>anne-marie.queuniet@chi-elbeuf-louviers.fr</email>
    </contact>
    <investigator>
      <last_name>Anne-Marie QUEUNIET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chicas</name>
      <address>
        <city>Gap</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéfanie ODDOU LAGRANIERE</last_name>
      <email>stefanie.oddou-lagraniere@chicas-gap.fr</email>
    </contact>
    <investigator>
      <last_name>Stéfanie ODDOU LAGRANIERE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne BEDU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier GUILLEM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHD Vendée</name>
      <address>
        <city>La Roche Sur Yon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roger FAROUX</last_name>
      <email>roger.faroux@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Roger FAROUX</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathieu SCNEE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Pierre LAFARGUE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Morgane AMIL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile GARCEAU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thierry CHARLOIS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-François RAMEE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elodie MENAGER-TABOUREL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique GIRRE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucile BAUGUION</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carelle KOUDOUGOU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Victor Hugo</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier DUPUIS</last_name>
      <email>o.dupuis@cjb72.org</email>
    </contact>
    <investigator>
      <last_name>Olivier DUPUIS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cédrik LAFOND</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hugues BOURGEOIS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johan POINTREAU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gérard GANEM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabrice DENIS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Robert Boulin</name>
      <address>
        <city>Libourne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence KIKOLSKI</last_name>
      <email>florence.kikolski@ch-libourne.fr</email>
    </contact>
    <investigator>
      <last_name>Florence KIKOLSKI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna MIHONIDOU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie CHERON</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie LE BRUN-LY</last_name>
      <email>valerie.lebrun@chu-limoges.fr</email>
    </contact>
    <investigator>
      <last_name>Valérie LE BRUN-LY</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine LAVAU DENES</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Hôpital du Surcoff</name>
      <address>
        <city>Lorient</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joëlle EGRETEAU</last_name>
      <email>j.egreteau@ch-bretagne-sud.fr</email>
    </contact>
    <investigator>
      <last_name>Joëlle EGRETEAU</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabelle CUMIN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Saint Joseph - Saint Luc</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis PERE-VERGE</last_name>
      <email>dpereverge@ch-stjoseph-stluc-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Denis PERE-VERGE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Audrey PASQUION</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bénédicte PROST</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU APHM Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed GASMI</last_name>
      <email>mohamed.gasmi@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Mohamed GASMI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Belinda AIDER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilie PIERA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU APHM La Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laëticia DAHAN</last_name>
      <email>laetitia.dahan@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Laëticia DAHAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-François SEITZ</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Muriel DULUC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuelle NORGUET</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Camille SIBERTIN-BLANC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen de Marseille</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves RINALDI</last_name>
      <email>y.rinaldi@hopital-europeen.fr; yrinaldi@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>Yves RINALDI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas BARRIERE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie GIGOUT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Céline JULIEN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Meaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe LOCHER</last_name>
      <email>c-locher@ch-meaux.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe LOCHER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc PRIETO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurence THOMAS MARQUES</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Farah ZEOUALA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Montelimar</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnès PELAQUIER</last_name>
      <email>agnes.pelaquier@ch-montelimar.fr; agnes.pelaquier@free.fr</email>
    </contact>
    <investigator>
      <last_name>Agnès PELAQUIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ahmed AZZEDINE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard DUVERT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura DEIANA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU - Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yann TOUCHEFEU</last_name>
      <email>yann.touchefeu@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Yann TOUCHEFEU</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tamara MATYSIAK-BUDNIK</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique de Languedoc</name>
      <address>
        <city>Narbonne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>André MATHIEU</last_name>
      <email>amathieu.narb@orange.fr</email>
    </contact>
    <investigator>
      <last_name>André MATHIEU</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincenzo GIARDINA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHR La Source</name>
      <address>
        <city>Orleans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Louis LEGOUX, MD</last_name>
      <phone>+33 2 38 51 47 04</phone>
      <email>jean-louis.legoux@chr-orleans.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Louis LEGOUX, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Paul LAGASSE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barbara DAUVOIS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bélinda TCHOUNDJEU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sofia HERRMANN GANDARA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU AP HP - GH Hôpital Pitié - Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Baptiste BACHET</last_name>
      <email>jean-baptiste.bachet@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Baptiste BACHET</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Solène DOAT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier DUBREUIL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédérik MORYOUSSEF</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Perpignan</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faïza KHEMISSA AKOUZ</last_name>
      <email>faiza.khemissa@ch-perpignan.fr</email>
    </contact>
    <investigator>
      <last_name>Faïza KHEMISSA AKOUZ</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CARIO - Hôpital Privé des Côte d'Armor</name>
      <address>
        <city>Plerin Sur Mer</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Luc ETIENNE</last_name>
      <email>pl.etienne@cario-sante.fr ; pl.etienne@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre-Luc ETIENNE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominique BESSON</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Claire HARDY-BESSARD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital de la Milétrie</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David TOUGERON</last_name>
      <email>david.tougeron@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>David TOUGERON</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurélie FERRU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul-Arthur HAINEAUX</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karine MOUMOUH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Annecy Genevois</name>
      <address>
        <city>Pringy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathieu BACONNIER</last_name>
      <email>mbaconnier@ch-annecygenevois.fr</email>
    </contact>
    <investigator>
      <last_name>Mathieu BACONNIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel MAILLARD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Eugène Marquis</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Astrid LIEVRE</last_name>
      <email>astrid.lievre@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Astrid LIEVRE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien EDELINE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samuel LE SOURD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc PRACHT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anaïs BODERE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bérangère LECONTE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie TALARMIN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fanny LE DU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire LARIBLE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric DI FIORE</last_name>
      <email>Frederic.Di-Fiore@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Frédéric DI FIORE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alice GANGLOFF</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre MICHEL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David SEFRIOUI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Basile PAUL</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charline MARRE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICO</name>
      <address>
        <city>Saint Herblain</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique GUERIN-MEYER</last_name>
      <email>veronique.guerin-meyer@ico.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Véronique GUERIN-MEYER</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jaafar BENNOUNA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine HIRET</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Yves DOUILLARD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Judith RAIMOURG</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hélène SENELLART</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique Côte Basque Sud</name>
      <address>
        <city>Saint Jean De Luz</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Etienne MAURIAC</last_name>
      <email>etiennemauriac@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Etienne MAURIAC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane REMY</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Saintonges</name>
      <address>
        <city>Saintes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence MOUGENOT BORDE</last_name>
      <phone>05 46 92 76 35</phone>
    </contact>
    <investigator>
      <last_name>Florence MOUGENOT BORDE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Corinne SARDA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Laura ANGHELESCU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de cancérologie Paris Nord</name>
      <address>
        <city>Sarcelles</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie GIROUX</last_name>
      <email>drjuliegiroux@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Julie GIROUX</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine BOAZIZ</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Sens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène COSME GASSMANN</last_name>
      <email>hcosme@ch-sens.fr</email>
    </contact>
    <investigator>
      <last_name>Hélène COSME GASSMANN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Bigorre</name>
      <address>
        <city>Tarbes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamran IMANI</last_name>
      <email>kimani@ch-tarbes-vic.fr</email>
    </contact>
    <investigator>
      <last_name>Kamran IMANI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre ANDRAU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leila KANAFI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hélène DESJARDINS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpitaux du Leman</name>
      <address>
        <city>Thonon Les Bains</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed BEDJAOUI</last_name>
      <email>a-bedjaoui@ch-hopitauxduleman.fr</email>
    </contact>
    <investigator>
      <last_name>Ahmed BEDJAOUI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Khoutir MAHOUR BACHA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent BALARDY</last_name>
      <email>balardy.l@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent BALARDY</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosine GUIMBAUD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Pascale LAURENTY</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Corinne COUTEAU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marion DESLANDRES</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphanie LOZANO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine BRECHEMIER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Garonne</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent BALARDY</last_name>
      <email>balardy.l@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent BALARDY</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphanie LOZANO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Delphine BRECHEMIER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Trousseau</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry LECOMTE</last_name>
      <email>thierry.lecomte@med.univ-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Thierry LECOMTE</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandre AUBOURG</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Pierre BARBIEUX</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Driffa MOUSSATA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine FEAU-LECERF</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Morgane CAULET</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Valencienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle BONNET</last_name>
      <email>bonnet-i@ch-valenciennes.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle BONNET</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thibaud RENAUT-VANTROYS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHBA</name>
      <address>
        <city>Vannes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis GRASSET</last_name>
      <email>denis.grasset@ch-bretagne-atlantique.fr</email>
    </contact>
    <investigator>
      <last_name>Denis GRASSET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David MALKA</last_name>
      <email>David.MALKA@gustaveroussy.fr</email>
    </contact>
    <investigator>
      <last_name>David MALKA</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal BURTIN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoine HOLLEBECQUE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel DUCREUX</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie BOIGE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles FERTE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé de Villeneuve d'Ascq</name>
      <address>
        <city>Villeneuve d'Ascq</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier ROMANO</last_name>
      <email>romanoolivier@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier ROMANO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2015</study_first_submitted>
  <study_first_submitted_qc>March 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2015</study_first_posted>
  <last_update_submitted>August 2, 2016</last_update_submitted>
  <last_update_submitted_qc>August 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cancer, colorectal,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

